The Effects of ASMase Mediated Endothelial Cell Apoptosis in Multiple Hypofractionated Irradiations in CT26 Tumor Bearing Mice

  • Zhu, Hong (Department of Medical Oncology, West China Hospital, Sichuan University) ;
  • Deng, Kai (Department of Gastroenterology, West China Hospital, Sichuan University) ;
  • Zhao, Ya-Qin (Department of Medical Oncology, West China Hospital, Sichuan University) ;
  • Wang, Xin (Department of Medical Oncology, West China Hospital, Sichuan University) ;
  • Shen, Ya-Li (Department of Medical Oncology, West China Hospital, Sichuan University) ;
  • Liu, Tai-Guo (Department of Medical Oncology, West China Hospital, Sichuan University) ;
  • Cui, Dan-Dan (Department of Medical Oncology, West China Hospital, Sichuan University) ;
  • Xu, Feng (Department of Medical Oncology, West China Hospital, Sichuan University)
  • Published : 2015.06.26


Background: To investigate the effects of ASMase mediated endothelial cell apoptosis in multiple hypofractionated irradiations in CT26 tumor bearing mice. Materials and Methods: Thirty-five CT26 tumor bearing mice were subjected to single ionizing radiation (IR) of 0, 3, 6, 9, 12, 15, 18 Gy. Eight hours after IR, the mice were sacrificed and tumor tissues were used for CD31 immunohistochemistry staining, TUNEL and CD31 double staining, ASMase activity assay. Then 6 and 12 Gy were chosen for multiple hypofractionated IR experiments according to the above results. Each time after IR, 5 mice were sacrificed and assayed as above. Results: The ASMase activities were increased significantly after a single IR of 12 Gy or higher which was accompanied with remarkable increased endothelial cell apoptosis and decreased MVD. For 6 Gy which was not high enough to trigger ASMase activation, after 2 or more times of IR, the ASMase activities were significantly increased accompanied with remarkable increased endothelial cell apoptosis and decreased MVD. While for 12 Gy, after 2 or more times of IR, the ASMase activities and endothelial cell apoptosis rates were maintained without remarkable increase; however, the MVD was significantly decreased. What's more, the cancer cell apoptosis rates were significantly increased after multiple IR for both 6 Gy and 12 Gy. Conclusions: ASMase mediated endothelial cell apoptosis may play an important role in the process of multiple hypofractionated IR for CT26 colorectal carcinoma.


ASMase;endothelial cell;hypofractionated irradiations;CT26 tumor bearing mice


Supported by : National Natural Scientific Foundation of China


  1. Bruns CJ, Shrader M, Harbison MT, et al (2002). Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. Int J Cancer, 102, 101-8.
  2. Chapet O, Udrescu C, Devonec M, et al (2013). Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall. Int J Radiat Oncol Biol Phys, 86, 72-6.
  3. Corre I, Niaudet C, Paris F (2010). Plasma membrane signaling induced by ionizing radiation. Mutat Res, 704, 61-7.
  4. Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S (2005). Role of early plasma membrane events in chemotherapyinduced cell death. Drug Resist Updat, 8, 5-14.
  5. Fuks Z, Kolesnick R (2005). Engaging the vascular component of the tumor response. Cancer Cell, 8, 89-91.
  6. Garcia-Barros M, Paris F, Cordon-Cardo C, et al (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science, 300, 1155-9.
  7. Garcia-Barros M, Thin TH, Maj J, et al (2010). Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res, 70, 8179-86.
  8. Gulbins E, Kolesnick R (2003). Raft ceramide in molecular medicine. Oncogene, 22, 7070-7.
  9. Haimovitz-Friedman A, Kan CC, Ehleiter D, et al (1994). Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med, 180, 525-35.
  10. Hua G, Kolesnick R (2013). Using ASMase knockout mice to model human diseases. Handb Exp Pharmacol, 216, 29-54.
  11. Kolesnick R, Fuks Z (2003). Radiation and ceramide-induced apoptosis. Oncogene, 22, 5897-906.
  12. Koukourakis MI, Giatromanolaki A, Tsoutsou P, et al (2011). Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study. Int J Radiat Oncol Biol Phys, 80, 492-8.
  13. Lan J, Wan XL, Deng L, et al (2013). Ablative hypofractionated radiotherapy normalizes tumor vasculature in lewis lung carcinoma mice model. Radiat Res, 179, 458-64.
  14. Li YQ, Chen P, Haimovitz-Friedman A, et al (2003). Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res, 63, 5950-6.
  15. Li ZJ, Zhu H, Ma BY, et al (2012). Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice. BMC Cancer, 12, 155.
  16. Longo CA, Tyler D, Mallampalli RK (1997). Sphingomyelin metabolism is developmentally regulated in rat lung. Am J Respir Cell Mol Biol, 16, 605-12.
  17. Moeller BJ, Dreher MR, Rabbani ZN, et al (2005). Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell, 8, 99-110.
  18. Nava VE, Cuvillier O, Edsall LC, et al (2000). Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res, 60, 4468-74.
  19. Osti MF, Agolli L, Valeriani M, et al (2013). Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 85, 157-63.
  20. Paris F, Fuks Z, Kang A, et al (2001). Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science, 293, 293-7.
  21. Park HJ, Griffin RJ, Hui S, et al (2012). Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res, 177, 311-27.
  22. Pena LA, Fuks Z, Kolesnick RN (2000). Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res, 60, 321-7.
  23. Pollard JM, Gatti RA (2009). Clinical radiation sensitivity with DNA repair disorders: an overview. Int J Radiat Oncol Biol Phys, 74, 1323-31.
  24. Rotolo JA, Maj JG, Feldman R, et al (2008). Bax and Bak do not exhibit functional redundancy in mediating radiationinduced endothelial apoptosis in the intestinal mucosa. Int J Radiat Oncol Biol Phys, 70, 804-15.
  25. Rotolo JA, Zhang J, Donepudi M, et al (2005). Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J Biol Chem, 280, 26425-34.
  26. Samet D, Barenholz Y (1999). Characterization of acidic and neutral sphingomyelinase activities in crude extracts of HL-60 cells. Chem Phys Lipids, 102, 65-77.
  27. Santana P, Pena LA, Haimovitz-Friedman A, et al (1996). Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell, 86, 189-99.
  28. Saponaro C, Malfettone A, Ranieri G, et al (2013). VEGF, HIF-1alpha expression and MVD as an angiogenic network in familial breast cancer. PLoS One, 8, 53070.
  29. Stancevic B, Kolesnick R (2010). Ceramide-rich platforms in transmembrane signaling. FEBS Lett, 584, 1728-40.
  30. Truman JP, Al Gadban MM, Smith KJ, Hammad SM (2011). Acid sphingomyelinase in macrophage biology. Cell Mol Life Sci, 68, 3293-305.
  31. Truman JP, Garcia-Barros M, Kaag M, et al (2010). Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One, 5, 9d04-4d120568a897.
  32. Utermohlen O, Karow U, Lohler J, Kronke M (2003). Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase. J Immunol, 170, 2621-8.
  33. Xu J, Yan X, Gao R, et al (2010). Effect of irradiation on microvascular endothelial cells of parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys, 78, 897-903.
  34. Zeidan YH, Hannun YA (2010). The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation. Curr Mol Med, 10, 454-66.
  35. Zeidan YH, Wu BX, Jenkins RW, et al (2008). A novel role for protein kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. Faseb J, 22, 183-93.
  36. Zeng H, Yuan Z, Zhu H, et al (2012). Expression of hPNAS-4 radiosensitizes lewis lung cancer. Int J Radiat Oncol Biol Phys, 24, 24.
  37. Zhang Y, Mattjus P, Schmid PC, et al (2001). Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis. J Biol Chem, 276, 11775-82.
  38. Zhu H, Li Z, Mao S, et al (2011). Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice. Cancer Gene Ther, 18, 884-96.

Cited by

  1. Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5 vol.59, pp.7, 2018,